PTGS2 and Alzheimer disease: Alzheimer′s disease patients′ brains also exhibit an increased expression of COX-2 [44,45,46], which through its effect on total amyloid precursor proteins (APP) is correlated with the severity of brain amyloid plaque pathology [44].